BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25692452)

  • 1. A Comparative Analysis of Bupivacaine and Ropivacaine Effects on Human Cardiac SCN5A Channels.
    Schwoerer AP; Scheel H; Friederich P
    Anesth Analg; 2015 Jun; 120(6):1226-34. PubMed ID: 25692452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetrodotoxin-sensitive α-subunits of voltage-gated sodium channels are relevant for inhibition of cardiac sodium currents by local anesthetics.
    Stoetzer C; Doll T; Stueber T; Herzog C; Echtermeyer F; Greulich F; Rudat C; Kispert A; Wegner F; Leffler A
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):625-36. PubMed ID: 27000037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The distinct effects of lipid emulsions used for "lipid resuscitation" on gating and bupivacaine-induced inhibition of the cardiac sodium channel Nav1.5.
    Nadrowitz F; Stoetzer C; Foadi N; Ahrens J; Wegner F; Lampert A; Koppert W; de la Roche J; Leffler A
    Anesth Analg; 2013 Nov; 117(5):1101-8. PubMed ID: 24029851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiotoxic Antiemetics Metoclopramide and Domperidone Block Cardiac Voltage-Gated Na+ Channels.
    Stoetzer C; Voelker M; Doll T; Heineke J; Wegner F; Leffler A
    Anesth Analg; 2017 Jan; 124(1):52-60. PubMed ID: 27861438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of ropivacaine with cloned cardiac Kv4.3/KChIP2.2 complexes.
    Friederich P; Solth A
    Anesthesiology; 2004 Dec; 101(6):1347-56. PubMed ID: 15564942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local-anesthetic like inhibition of the cardiac sodium channel Nav1.5 α-subunit by 5-HT3 receptor antagonists.
    Van't Klooster MP; Foadi N; Hage A; Stoetzer C; Wegner F; Eberhardt M; Leffler A
    Eur J Pharmacol; 2016 Oct; 789():119-126. PubMed ID: 27401036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent Inactivation-Dependent Inhibition of Adult and Neonatal NaV1.5 Channels by Lidocaine and Levobupivacaine.
    Elajnaf T; Baptista-Hon DT; Hales TG
    Anesth Analg; 2018 Sep; 127(3):650-660. PubMed ID: 29958221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent inhibition by ropivacaine of metastatic colon cancer SW620 cell invasion and NaV1.5 channel function.
    Baptista-Hon DT; Robertson FM; Robertson GB; Owen SJ; Rogers GW; Lydon EL; Lee NH; Hales TG
    Br J Anaesth; 2014 Jul; 113 Suppl 1():i39-i48. PubMed ID: 24852501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of hesperetin on Nav1.5 channels stably expressed in HEK 293 cells and on the voltage-gated cardiac sodium current in human atrial myocytes.
    Wang H; Wang HF; Zhang H; Wang C; Chen YF; Ma R; Xiang JZ; Du XL; Tang Q
    Acta Pharmacol Sin; 2016 Dec; 37(12):1563-1573. PubMed ID: 27694909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amide local anesthetics potently inhibit the human tandem pore domain background K+ channel TASK-2 (KCNK5).
    Kindler CH; Paul M; Zou H; Liu C; Winegar BD; Gray AT; Yost CS
    J Pharmacol Exp Ther; 2003 Jul; 306(1):84-92. PubMed ID: 12660311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological modulation of brain Nav1.2 and cardiac Nav1.5 subtypes by the local anesthetic ropivacaine.
    Cheng HW; Yang HT; Zhou JJ; Ji YH; Zhu HY
    Neurosci Bull; 2010 Aug; 26(4):289-96. PubMed ID: 20651810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of CNS site-directed carotid arterial infusions of bupivacaine, levobupivacaine, and ropivacaine in sheep.
    Ladd LA; Chang DH; Wilson KA; Copeland SE; Plummer JL; Mather LE
    Anesthesiology; 2002 Aug; 97(2):418-28. PubMed ID: 12151933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the cardiac Na⁺ channel α-subunit Nav1.5 by propofol and dexmedetomidine.
    Stoetzer C; Reuter S; Doll T; Foadi N; Wegner F; Leffler A
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Mar; 389(3):315-25. PubMed ID: 26667357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of peripheral Na(+) channels and neuronal firing by n-butyl-p-aminobenzoate.
    Thériault O; Poulin H; Sculptoreanu A; de Groat WC; O'Leary ME; Chahine M
    Eur J Pharmacol; 2014 Mar; 727():158-66. PubMed ID: 24486399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cytotoxicity of bupivacaine, ropivacaine, and mepivacaine on human chondrocytes and cartilage.
    Breu A; Rosenmeier K; Kujat R; Angele P; Zink W
    Anesth Analg; 2013 Aug; 117(2):514-22. PubMed ID: 23749443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in cardiotoxicity of bupivacaine and ropivacaine are the result of physicochemical and stereoselective properties.
    Graf BM; Abraham I; Eberbach N; Kunst G; Stowe DF; Martin E
    Anesthesiology; 2002 Jun; 96(6):1427-34. PubMed ID: 12170056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The opioid methadone induces a local anaesthetic-like inhibition of the cardiac Na⁺ channel, Na(v)1.5.
    Schulze V; Stoetzer C; O'Reilly AO; Eberhardt E; Foadi N; Ahrens J; Wegner F; Lampert A; de la Roche J; Leffler A
    Br J Pharmacol; 2014 Jan; 171(2):427-37. PubMed ID: 24117196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselective block of cardiac sodium channels by bupivacaine in guinea pig ventricular myocytes.
    Valenzuela C; Snyders DJ; Bennett PB; Tamargo J; Hondeghem LM
    Circulation; 1995 Nov; 92(10):3014-24. PubMed ID: 7586272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cardiotoxicity of local anesthetics: the place of ropivacaine.
    Graf BM
    Curr Top Med Chem; 2001 Aug; 1(3):207-14. PubMed ID: 11895138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of A-803467 on cardiac Nav1.5 channels.
    Han Z; Jiang Y; Xiao F; Cao K; Wang DW
    Eur J Pharmacol; 2015 May; 754():52-60. PubMed ID: 25701724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.